Quick Answer
Rallybio Corp reported Earnings Per Share Diluted of $1.59 (loss) per share for the year ending 2025.
- Rallybio Corp showed an increase of +85.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Rallybio Corp's annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $0.49 (loss) per share | Q3 2021: $0.37 (loss) per share | Q1 2022: $0.48 (loss) per share | Q2 2022: $0.57 (loss) per share | Q3 2022: $0.60 (loss) per share | Q1 2023: $0.43 (loss) per share | Q2 2023: $0.46 (loss) per share | Q3 2023: $0.45 (loss) per share | Q1 2024: $0.47 (loss) per share | Q2 2024: $0.37 (loss) per share | Q3 2024: $0.26 (loss) per share | Q1 2025: $0.21 (loss) per share | Q2 2025: $0.22 (loss) per share | Q3 2025: $0.36 per share.
- Over the full 5 years of available data (2021 to 2025), Rallybio Corp's Earnings Per Share Diluted has grown by 13.6%.
- Historical annual values: Fiscal year 2025: $1.59 (loss) per share | Fiscal year 2024: $10.61 (loss) per share | Fiscal year 2023: $1.84 (loss) per share | Fiscal year 2022: $2.09 (loss) per share | Fiscal year 2021: $1.84 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: